CENTRAL NERVOUS SYSTEM GRAFT VERSUS HOST DISEASE PATHOPHYSIOLOGY: MECHANISTIC PATHWAYS AND THERAPEUTIC TARGETS

The development of graft versus host disease (GVHD) in the central nervous system (CNS) is a recognized complication that can lead to significant morbidity and mortality in allogeneic hematopoietic stem cell transplant recipients. In this article, we describe clinical manifestations and elucidate some of the diagnostic challenges associated with this disease entity. We then summarize new experimental insights that have emerged largely from pre-clinical murine studies that have investigated the pathophysiology of CNS GVHD. We delineate the vascular and lymphatic systems that regulate ingress and egress of soluble mediators and cellular populations, thereby functioning as specialized barriers that shield the brain under normal homeostatic conditions, and how these barriers are disrupted during GVHD-induced peripheral immune dysregulation. We also review pre-clinical studies that have uncovered mechanistic neuroinflammatory pathways involving cytokines (IL-6, TNF-α), cell surface receptors (type 2 cannabinoid receptor, colony stimulating factor-1 receptor) expressed on adaptive and innate immune cells, and antibiotic-induced gastrointestinal tract dysbiosis that have pathophysiological roles in this disorder. In addition, we provide evidence derived from these pre-clinical studies that the therapeutic targeting of individual pathways to attenuate CNS GVHD does not necessarily produce concordant responses in peripheral GVHD target organs, highlighting that the brain is a compartmentalized tissue site with a distinct microenvironment and supporting a more nuanced view of GVHD biology across CNS and non-CNS regions. Finally, we examine alternate therapeutic strategies to restore barrier integrity and thereby reduce T cell trafficking into the CNS to attenuate GVHD-associated neuroinflammation.

Authors

Institutions

Publication Details

Journal
Blood
Published
2026-11-16
DOI
https://doi.org/10.1182/blood.2026035230
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CENTRAL NERVOUS SYSTEM GRAFT VERSUS HOST DISEASE PATHOPHYSIOLOGY: MECHANISTIC PATHWAYS AND THERAPEUTIC TARGETS

Aditya Rayasam, Cecilia J. Hillard, William R. Drobyski
Blood
Hematopoietic Stem Cell Transplantation
article

CENTRAL NERVOUS SYSTEM GRAFT VERSUS HOST DISEASE PATHOPHYSIOLOGY: MECHANISTIC PATHWAYS AND THERAPEUTIC TARGETS

Aditya Rayasam, Cecilia J. Hillard, William R. Drobyski
article en

Abstract

The development of graft versus host disease (GVHD) in the central nervous system (CNS) is a recognized complication that can lead to significant morbidity and mortality in allogeneic hematopoietic stem cell transplant recipients. In this article, we describe clinical manifestations and elucidate some of the diagnostic challenges associated with this disease entity. We then summarize new experimental insights that have emerged largely from pre-clinical murine studies that have investigated the pathophysiology of CNS GVHD. We delineate the vascular and lymphatic systems that regulate ingress and egress of soluble mediators and cellular populations, thereby functioning as specialized barriers that shield the brain under normal homeostatic conditions, and how these barriers are disrupted during GVHD-induced peripheral immune dysregulation. We also review pre-clinical studies that have uncovered mechanistic neuroinflammatory pathways involving cytokines (IL-6, TNF-α), cell surface receptors (type 2 cannabinoid receptor, colony stimulating factor-1 receptor) expressed on adaptive and innate immune cells, and antibiotic-induced gastrointestinal tract dysbiosis that have pathophysiological roles in this disorder. In addition, we provide evidence derived from these pre-clinical studies that the therapeutic targeting of individual pathways to attenuate CNS GVHD does not necessarily produce concordant responses in peripheral GVHD target organs, highlighting that the brain is a compartmentalized tissue site with a distinct microenvironment and supporting a more nuanced view of GVHD biology across CNS and non-CNS regions. Finally, we examine alternate therapeutic strategies to restore barrier integrity and thereby reduce T cell trafficking into the CNS to attenuate GVHD-associated neuroinflammation.

Blood
Medical College of Wisconsin (US)
Good health and well-being
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon